Skip to main content

Advertisement

Log in

Current status of MRI-guided vacuum-assisted breast biopsy in Japan

  • Special Feature
  • High-risk screening: up-to-date
  • Published:
Breast Cancer Aims and scope Submit manuscript

Abstract

In April 2018, the national health insurance coverage of MRI-guided vacuum-assisted breast biopsy (VAB) was instituted with the application of the Japan Breast Cancer Society. Although MRI-guided VAB has been considered as a special procedure for a long time, having an access to this procedure should be recommended for facilities performing breast MRI as in Western countries. From now on, relevant societies should make efforts in data collection and quality control of MRI-guided VAB in Japan. We must avoid the following. To delay the early diagnosis of breast cancer in the judgment of an inaccurate indication, perform unnecessary biopsy due to overestimation of diagnosis, and reduce the success rate of MRI-guided VAB with immature techniques. This review explains the current status of MRI-guided VAB in Japan and shares procedure and biopsy data as a future reference from an experienced facility.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  1. Tozaki M, Yamashiro N, Fukuma E. MR-guided vacuum-assisted breast biopsy using a non-titanium needle. Magn Reson Med Sci. 2007;6(4):259–64.

    Article  Google Scholar 

  2. Tozaki M, Yamashiro N, Suzuki T, Kawano N, Ozaki S, Sakamoto N, et al. MR-guided vacuum-assisted breast biopsy: is it an essential technique? Breast Cancer. 2009;16(2):121–5.

    Article  Google Scholar 

  3. Tozaki M, Yamashiro N, Sakamoto M, Sakamoto N, Mizuuchi N, Fukuma E. MR-guided vacuum-assisted breast biopsy: results in 100 Japanese women. Jpn J Radiol. 2010;28(7):527–33.

    Article  Google Scholar 

  4. ACR practice parameter for the performance of magnetic resonance imaging-guided breast interventional procedures. American College of Radiology; 2016. (https://www.acr.org/-/media/ACR/Files/Practice-Parameters/MR-Guided-Breast.pdf#search=%27ACR%2C+MRguided+biopsy%27).

  5. Suzuki T, Tozaki M, Yamashiro N, Sakamoto N, Abe S, Hoshi K, et al. A case of breast cancer in which MRI detected an abnormality two years before diagnosis (in Japanese with English abstract). Jpn J Breast Cancer. 2008;23:557–60.

    Google Scholar 

  6. LaTrenta LR, Menell JH, Morris EA, Abramson AF, Dershaw DD, Liberman L. Breast lesions detected with MR imaging: utility and histopathologic importance of identification with US. Radiology. 2003;227:856–61.

    Article  Google Scholar 

  7. Sakamoto N, Tozaki M, Fukuma E, Higa K, Tsunoda Y, Abe S, et al. The role of ultrasound-guided vacuum-assisted biopsy in the management of MRI-detected lesions (in Japanese with English abstract). Jpn J Breast Cancer. 2007;22:275–9.

    Google Scholar 

  8. Morris EA, Liberman L, Dershaw DD, Kaplan JB, LaTrenta LR, Abramson AF, et al. Preoperative MR imaging-guided needle localization of breast lesions. AJR Am J Roentgenol. 2002;178:1211–20.

    Article  Google Scholar 

  9. Fischer U, Vosshenrich R, Keating D, Bruhn H, Döler W, Oestmann JW, et al. MR-guided biopsy of suspect breast lesions with a simple stereotaxic add-on device for surface coils. Radiology. 1994;192:272–3.

    Article  CAS  Google Scholar 

  10. Fischer U, Vosshenrich R, Döler W, Hamadeh A, Oestmann JW, Grabbe E. MR imaging-guided breast intervention: experience with two systems. Radiology. 1995;195:533–8.

    Article  CAS  Google Scholar 

  11. Kuhl CK, Elevelt A, Leutner CC, Gieseke J, Pakos E, Schild HH. Interventional breast MR imaging: clinical use of a stereotactic localization and biopsy device. Radiology. 1997;204:667–75.

    Article  CAS  Google Scholar 

  12. Kuhl CK, Morakkabati N, Leutner CC, Schmiedel A, Wardelmann E, Schild HH. MR imaging-guided large-core (14-gauge) needle biopsy of small lesions visible at breast MR imaging alone. Radiology. 2001;220:31–9.

    Article  CAS  Google Scholar 

  13. Heywang-Köbrunner SH, Heinig A, Schaumlöffel U, Viehweg P, Buchmann J, Lampe D, et al. MR-guided percutaneous excisional and incisional biopsy of breast lesions. Eur Radiol. 1999;9:1656–65.

    Article  Google Scholar 

  14. Perlet C, Heinig A, Prat X, Casselman J, Baath L, Sittek H, et al. Multicenter study for the evaluation of a dedicated biopsy device for MR-guided vacuum biopsy of the breast. Eur Radiol. 2002;12:1463–70.

    Article  CAS  Google Scholar 

  15. Prat X, Sittek H, Grosse A, Baath L, Perlet C, Alberich T, et al. European quadricentric evaluation of a breast MR biopsy and localization device: technical improvements based on phase-I evaluation. Eur Radiol. 2002;12:1720–7.

    Article  CAS  Google Scholar 

  16. Viehweg P, Heinig A, Amaya B, Alberich T, Laniado M, Heywang-Köbrunner SH. MR-guided interventional breast procedures considering vacuum biopsy in particular. Eur J Radiol. 2002;42:32–9.

    Article  CAS  Google Scholar 

  17. Perlet C, Heywang-Kobrunner SH, Heinig A, Sittek H, Casselman J, Anderson I, et al. Magnetic resonance-guided, vacuum-assisted breast biopsy: Results from a European multicenter study of 538 lesions. Cancer. 2006;106(5):982–90.

    Article  Google Scholar 

  18. Sakamoto N, Tozaki M, Higa K, Abe S, Ozaki S, Fukuma E. False-negative ultrasound-guided vacuum-assisted biopsy of the breast: difference with US-detected and MRI-detected lesions. Breast Cancer. 2010;17(2):110–7.

    Article  Google Scholar 

  19. Uematsu T, Takahashi K, Nishimura S, Watanabe J, Yamasaki S, Sugino T, et al. Real-time virtual sonography examination and biopsy for suspicious breast lesions identified on MRI alone. Eur Radiol. 2016;26(4):1064–72.

    Article  Google Scholar 

  20. Izumori A, Kokubu Y, Sato K, Gomi N, Morizono H, Sakai T, et al. Usefulness of second-look ultrasonography using anatomical breast structures as indicators for magnetic resonance imaging-detected breast abnormalities. Breast Cancer. 2020;27(1):129–39.

    Article  Google Scholar 

  21. Nakamura S, Takahashi M, Tozaki M, Nakayama T, Nomizu T, Miki Y, et al. Prevalence and differentiation of hereditary breast and ovarian cancers in Japan. Breast Cancer. 2015;22(5):462–8.

    Article  Google Scholar 

  22. Murakami W, Tozaki M, Nakamura S, Ide Y, Inuzuka M, Hirota Y, et al. The clinical impact of MRI screening for BRCA mutation carriers: the first report in Japan. Breast Cancer. 2019;26(5):552–61.

    Article  Google Scholar 

  23. Tozaki M. Current status of MRI-guided biopsy and construction of training system (in Japanese with English abstract). Jpn J Breast Cancer. 2019;34(4):311–4.

    Google Scholar 

  24. Heller SL, Moy L. Imaging features and management of high-risk lesions on contrast-enhanced dynamic breast MRI. AJR Am J Roentgenol. 2012;198(2):249–55.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Mitsuhiro Tozaki.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Takahama, N., Tozaki, M. & Ohgiya, Y. Current status of MRI-guided vacuum-assisted breast biopsy in Japan. Breast Cancer 28, 1188–1194 (2021). https://doi.org/10.1007/s12282-020-01107-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12282-020-01107-x

Keywords

Navigation